Thank you for following Washington Examiner. You will receive email notifications for this source. To make changes to this, please visit your account.
You need to upgrade in order to follow more news source and receive email notifications about new articles and ratings, as your subscription allows only source. To change which news sources you follow, please visit your account.
Merck sues over drug price negotiations in Democratic Inflation Reduction Act
The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.
Reliability Score Analysis
Policy Leaning Analysis
Politician Portrayal Analysis
Bias Meter
Extremely Liberal
Very Liberal
Moderately Liberal
Somewhat Liberal
Center
Somewhat Conservative
Moderately Conservative
Very Conservative
Extremely Conservative
-100% Liberal
100% Conservative
Contributing sentiments towards policy:
44% : Participation in government-set prices is not voluntary but rather enforced by excise taxes and monetary penalties that can range up to 95% of the drug's sales revenue.
*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.
Washington Examiner